TW200640946A - Method of producing protein by using hamster igf-1 - Google Patents
Method of producing protein by using hamster igf-1Info
- Publication number
- TW200640946A TW200640946A TW095105658A TW95105658A TW200640946A TW 200640946 A TW200640946 A TW 200640946A TW 095105658 A TW095105658 A TW 095105658A TW 95105658 A TW95105658 A TW 95105658A TW 200640946 A TW200640946 A TW 200640946A
- Authority
- TW
- Taiwan
- Prior art keywords
- amino acid
- polypeptide
- acid sequence
- producing protein
- igf
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 241000699800 Cricetinae Species 0.000 title 1
- 101150088952 IGF1 gene Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 4
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 abstract 2
- 102100037852 Insulin-like growth factor I Human genes 0.000 abstract 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Microbiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005044625 | 2005-02-21 | ||
| JP2005275485 | 2005-09-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200640946A true TW200640946A (en) | 2006-12-01 |
| TWI406870B TWI406870B (zh) | 2013-09-01 |
Family
ID=36916594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095105658A TWI406870B (zh) | 2005-02-21 | 2006-02-20 | A method of making a protein using hamster IGF-1 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8062863B2 (zh) |
| EP (2) | EP1857465A4 (zh) |
| JP (1) | JP4999677B2 (zh) |
| KR (1) | KR101273001B1 (zh) |
| CN (1) | CN101151276B (zh) |
| AU (1) | AU2006215012B8 (zh) |
| CA (1) | CA2598570C (zh) |
| HK (1) | HK1112254A1 (zh) |
| SG (1) | SG174827A1 (zh) |
| TW (1) | TWI406870B (zh) |
| WO (1) | WO2006088198A1 (zh) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3852636T2 (de) * | 1987-12-24 | 1995-05-04 | Gropep Pty Ltd | Peptid-analoge vom insulinähnlichen wachstums-faktor 1 (igf-1) oder faktor 2 (igf-2). |
| EP0546073B1 (en) | 1990-08-29 | 1997-09-10 | GenPharm International, Inc. | production and use of transgenic non-human animals capable of producing heterologous antibodies |
| WO1993002227A1 (en) | 1991-07-15 | 1993-02-04 | Eco-Tec Limited | Process and apparatus for treating fluoride containing acid solutions |
| AU675661B2 (en) | 1992-07-24 | 1997-02-13 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US5285485A (en) | 1993-02-01 | 1994-02-08 | General Electric Company | Composite nuclear fuel container and method for producing same |
| JPH08509612A (ja) | 1993-04-26 | 1996-10-15 | ジェンファーム インターナショナル インコーポレイテッド | 異種抗体を産生することができるトランスジェニック非ヒト動物 |
| JP3630453B2 (ja) | 1994-09-30 | 2005-03-16 | 中外製薬株式会社 | Ｉｌ−６レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤 |
| EP1978033A3 (en) | 1995-04-27 | 2008-12-24 | Amgen Fremont Inc. | Human antibodies derived from immunized xenomice |
| CA2219486A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| AUPN442295A0 (en) * | 1995-07-26 | 1995-08-17 | Commonwealth Scientific And Industrial Research Organisation | Regulated autocrine growth of mammalian cells |
| AU762351B2 (en) * | 1999-01-06 | 2003-06-26 | Genentech Inc. | Insulin-like growth factor (IGF) I mutant variants |
| DE60042550D1 (de) * | 1999-01-06 | 2009-08-27 | Genentech Inc | Mutierte varianten des insulin-ähnlichen wachstumsfaktor i (igf-i) |
| US7469185B2 (en) * | 2002-02-04 | 2008-12-23 | Ocimum Biosolutions, Inc. | Primary rat hepatocyte toxicity modeling |
| WO2006025879A2 (en) * | 2004-05-11 | 2006-03-09 | Wyeth | Novel polynucleotides related to oligonucleotide arrays to monitor gene expression |
-
2006
- 2006-02-20 TW TW095105658A patent/TWI406870B/zh not_active IP Right Cessation
- 2006-02-21 US US11/884,538 patent/US8062863B2/en not_active Expired - Fee Related
- 2006-02-21 AU AU2006215012A patent/AU2006215012B8/en not_active Ceased
- 2006-02-21 EP EP06714185A patent/EP1857465A4/en not_active Withdrawn
- 2006-02-21 WO PCT/JP2006/303045 patent/WO2006088198A1/ja active Application Filing
- 2006-02-21 EP EP09176322.7A patent/EP2172480B1/en not_active Not-in-force
- 2006-02-21 CN CN2006800102988A patent/CN101151276B/zh not_active Expired - Fee Related
- 2006-02-21 JP JP2007503780A patent/JP4999677B2/ja not_active Expired - Fee Related
- 2006-02-21 CA CA2598570A patent/CA2598570C/en not_active Expired - Fee Related
- 2006-02-21 KR KR1020077020531A patent/KR101273001B1/ko active IP Right Grant
- 2006-02-21 SG SG2011067550A patent/SG174827A1/en unknown
-
2008
- 2008-07-10 HK HK08107585.8A patent/HK1112254A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2598570A1 (en) | 2006-08-24 |
| TWI406870B (zh) | 2013-09-01 |
| AU2006215012B2 (en) | 2012-02-09 |
| KR20070115945A (ko) | 2007-12-06 |
| JP4999677B2 (ja) | 2012-08-15 |
| CA2598570C (en) | 2016-03-22 |
| EP2172480B1 (en) | 2013-08-14 |
| JPWO2006088198A1 (ja) | 2008-07-03 |
| KR101273001B1 (ko) | 2013-06-10 |
| AU2006215012B8 (en) | 2012-04-12 |
| US8062863B2 (en) | 2011-11-22 |
| EP1857465A1 (en) | 2007-11-21 |
| CN101151276B (zh) | 2012-10-10 |
| EP2172480A2 (en) | 2010-04-07 |
| EP1857465A4 (en) | 2009-01-28 |
| EP2172480A3 (en) | 2010-09-08 |
| US20090011453A1 (en) | 2009-01-08 |
| HK1112254A1 (en) | 2008-08-29 |
| WO2006088198A1 (ja) | 2006-08-24 |
| SG174827A1 (en) | 2011-10-28 |
| CN101151276A (zh) | 2008-03-26 |
| AU2006215012A1 (en) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1801206A4 (en) | PROCESS FOR THE PREPARATION OF L-ARGININE, L-ORNITHIN OR L-CITRULLINE | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| ATE421977T1 (de) | Reinigung von peptiden unter verwendung von metall-ion-affinitätschromatographie | |
| IN2014CN02050A (zh) | ||
| WO1998021343B1 (en) | Genes encoding telomerase proteins | |
| CA2180103A1 (en) | Gene encoding adseverin | |
| ATE408016T1 (de) | Verfahren zur herstellung und sekretion modifizierter peptide | |
| EP0889133A3 (en) | Process for producing microbial transglutaminase | |
| WO2006042719A3 (de) | Polypeptid mit phytaseaktivität und dieses codierende nucleotidsequenz | |
| US9803207B2 (en) | Expression vector for production of recombinant proteins in prokaryotic host cells | |
| AU8649698A (en) | Cell cycle-regulating proteins | |
| WO2007058267A8 (ja) | 新規タンパク質及びそれをコードする遺伝子 | |
| UA92913C2 (ru) | Экспрессионный вектор и способы продуцирования высоких уровней белков | |
| CA2390049A1 (en) | Control of post-transcriptional gene silencing in plants | |
| CA2399378A1 (en) | Sodium-independent small neutral amino acid transporters transporting l- and d-amino acids and genes thereof | |
| TW200640946A (en) | Method of producing protein by using hamster igf-1 | |
| EP1757687A4 (en) | HLA BINDING PEPTIDE, PRE-STEP, DNA DOMAGING AND RECOMBINANT VECTOR | |
| DE60028217D1 (de) | Zyklische depsipeptid-synthasen, deren gene und system zur massenproduktion von zyklischen depsipeptiden | |
| WO2002010384A1 (fr) | Genes codant des proteines capables de regenerer la luciferine, adn recombine et methode de production de proteines capables de regenerer la luciferine | |
| WO2003025182A1 (fr) | Adn de surexpression d'une hormone de croissance et utilisation | |
| WO2008108345A1 (ja) | 耐虫性タンパク質及び該耐虫性タンパク質をコードする耐虫性遺伝子 | |
| CA2348732A1 (en) | Human h37 proteins and cdnas encoding the same | |
| CA2422295A1 (en) | A gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene | |
| SG170757A1 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
| EP0750040A3 (en) | Macrophage stimulating protein variant and method for producing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |